| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Medicine, St. Lukes Medical Center (J.L.S.), Milwaukee, Wisconsin 53215; and the Departments of Radiology (W.R.R.) and Medicine (M.P.W.), Division of Bone and Mineral Diseases, Washington University School of Medicine, Barnes-Jewish Hospital, St. Louis, Missouri 63110
Address all correspondence and requests for reprints to: Joseph L. Shaker, M.D., Department of Medicine, St. Lukes Medical Center, 2901 West Kinnickinnic River Parkway, Suite 503, Milwaukee, Wisconsin 53215. E-mail: jshaker{at}execpc.com
A 69-yr-old woman with hepatitis C virus (HCV) infection from blood transfusion 14 yr earlier was evaluated in 1997 for increasing appendicular skeletal pain. Diffusely elevated radioisotope uptake on bone scanning had appeared during the past 15 months. Radiographs spanning 19781997 showed remarkable restoration of bone mass and a skeleton like that of a young woman. Bone mineral densities of the femoral neck and lumbar spine were above the mean peak bone mass of young women (T scores, +1.8 and +1.3, respectively) and 160% and 147% of mean values for age-matched female controls (Z-score, +3.7 and +3.6, respectively). Biochemical markers of skeletal remodeling were substantially increased. Bone marrow biopsy showed normal lamellar bone. Serum alkaline phosphatase activity assays suggested that accelerated skeletal turnover began 612 months before symptoms.
HC-associated osteosclerosis has been reported in nine individuals 2773 yr of age, most with a history of iv drug abuse. Our patient demonstrates that parenteral exposure to blood rather than illicit drugs is the feature common to all affected subjects. Furthermore, we document that there can be a long latency between HCV infection and the development of skeletal abnormalities. We also find that bone mass can be restored by this disorder in a postmenopausal woman. Routine radiographs, however, may not show overt osteosclerosis in the elderly. The precise pathogenesis of this disorder is unknown. Understanding and control of the mechanism of HC-associated osteosclerosis could potentially lead to correction of low bone mass from osteoporosis with good quality skeletal tissue.
This article has been cited by other articles:
![]() |
E. K. Chow, A. Castrillo, A. Shahangian, L. Pei, R. M. O'Connell, R. L. Modlin, P. Tontonoz, and G. Cheng A role for IRF3-dependent RXR{alpha} repression in hepatotoxicity associated with viral infections J. Exp. Med., November 27, 2006; 203(12): 2589 - 2602. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khosla and C. A. Conover Insulin-Like Growth Factor (IGF)-II/IGF-Binding Proteins in Constitutionally Tall Children J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1912 - 1913. [Full Text] |
||||
![]() |
S. Khosla, F. J. Ballard, and C. A. Conover Use of Site-Specific Antibodies to Characterize the Circulating Form of Big Insulin-Like Growth Factor II in Patients with Hepatitis C-Associated Osteosclerosis J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3867 - 3870. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Shaker, B. P. Moore, and M. P. Whyte Hyperparathyroidism and Increased Serum IGF-Binding Protein-2 Levels in Hepatitis C-Associated Osteosclerosis J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 384a - 385. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |